A detailed history of Huntington National Bank transactions in Repligen Corp stock. As of the latest transaction made, Huntington National Bank holds 267 shares of RGEN stock, worth $37,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares
267
Previous 243 9.88%
Holding current value
$37,086
Previous $30,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.79 - $167.35 $2,874 - $4,016
24 Added 9.88%
267 $39,000
Q2 2024

Aug 08, 2024

SELL
$120.0 - $182.95 $3,960 - $6,037
-33 Reduced 11.96%
243 $30,000
Q1 2024

May 03, 2024

BUY
$170.78 - $208.42 $4,098 - $5,002
24 Added 9.52%
276 $50,000
Q3 2023

Nov 08, 2023

SELL
$138.78 - $176.51 $3,885 - $4,942
-28 Reduced 10.0%
252 $40,000
Q2 2023

Aug 11, 2023

BUY
$138.42 - $180.31 $1,107 - $1,442
8 Added 2.94%
280 $39,000
Q1 2023

May 10, 2023

BUY
$154.26 - $198.1 $7,404 - $9,508
48 Added 21.43%
272 $45,000
Q4 2022

Feb 09, 2023

BUY
$162.42 - $220.56 $4,710 - $6,396
29 Added 14.87%
224 $37,000
Q3 2022

Nov 07, 2022

SELL
$160.42 - $256.21 $802 - $1,281
-5 Reduced 2.5%
195 $36,000
Q2 2022

Aug 09, 2022

SELL
$140.68 - $188.02 $2,110 - $2,820
-15 Reduced 6.98%
200 $32,000
Q1 2022

May 10, 2022

BUY
$161.19 - $257.96 $5,480 - $8,770
34 Added 18.78%
215 $40,000
Q4 2021

Jan 21, 2022

SELL
$247.59 - $304.47 $247 - $304
-1 Reduced 0.55%
181 $48,000
Q3 2021

Oct 28, 2021

SELL
$194.77 - $324.21 $21,229 - $35,338
-109 Reduced 37.46%
182 $53,000
Q2 2021

Jul 30, 2021

BUY
$165.87 - $220.95 $15,094 - $20,106
91 Added 45.5%
291 $58,000
Q1 2021

Apr 12, 2021

BUY
$180.37 - $226.26 $12,625 - $15,838
70 Added 53.85%
200 $39,000
Q4 2020

Jan 11, 2021

SELL
$148.08 - $206.57 $6,663 - $9,295
-45 Reduced 25.71%
130 $25,000
Q2 2020

Jul 30, 2020

BUY
$94.33 - $140.48 $8,301 - $12,362
88 Added 101.15%
175 $22,000
Q1 2020

Apr 27, 2020

SELL
$84.96 - $109.14 $15,377 - $19,754
-181 Reduced 67.54%
87 $8,000
Q4 2019

Jan 17, 2020

SELL
$73.84 - $93.08 $2,289 - $2,885
-31 Reduced 10.37%
268 $25,000
Q3 2019

Nov 01, 2019

SELL
$76.65 - $95.51 $9,581 - $11,938
-125 Reduced 29.48%
299 $23,000
Q1 2019

Apr 09, 2019

BUY
$49.45 - $62.8 $20,966 - $26,627
424 New
424 $25,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.71B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.